Related references
Note: Only part of the references are listed.Remdesivir Efficacy in COVID-19 Treatment: A Randomized Controlled Trial
Sherief Abd-Elsalam et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2022)
Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points
Anjum S. Kaka et al.
ANNALS OF INTERNAL MEDICINE (2022)
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
Florence Ader et al.
LANCET INFECTIOUS DISEASES (2022)
Remdesivir for Adults With COVID-19 A Living Systematic Review for American College of Physicians Practice Points
Timothy J. Wilt et al.
ANNALS OF INTERNAL MEDICINE (2021)
Update Alert 2: Remdesivir for Adults With COVID-19
Anjum S. Kaka et al.
ANNALS OF INTERNAL MEDICINE (2021)
Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2021)
Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2021)
Major Update: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points
Anjum S. Kaka et al.
ANNALS OF INTERNAL MEDICINE (2021)
The Development of Living, Rapid Practice Points: Summary of Methods From the Scientific Medical Policy Committee of the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2021)
Update Alert: Remdesivir for Adults With COVID-19
Anjum S. Kaka et al.
ANNALS OF INTERNAL MEDICINE (2021)
Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2021)
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 A Randomized Trial
Andreas Barratt-Due et al.
ANNALS OF INTERNAL MEDICINE (2021)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)